Who Paid My Doc
Er-Reboa
Device Dqy
General payments
$75,860
Research payments
$75,872
Through program year 2022, $75,860 in general payments and $75,872 in research payments were reported against Er-Reboa (Dqy).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $108 | 1 |
| 2020 | General | $3,080 | 60 |
| 2020 | Research | $18,461 | 7 |
| 2019 | General | $72,672 | 254 |
| 2019 | Research | $57,411 | 5 |
Breakdown
Each share is of general payments naming this product in 2022.
Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2022 where a state was reported.
Records
315 general · 12 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.